Suppr超能文献

FOXP1 和 KLF2 相互调节 CAR T 细胞干性向效应性转变的检查点。

FOXP1 and KLF2 reciprocally regulate checkpoints of stem-like to effector transition in CAR T cells.

机构信息

Department of Immunology, University of Texas Southwestern Medical Center, Dallas, TX, USA.

Immunology Ph.D. Program, University of Texas Southwestern Medical Center, Dallas, TX, USA.

出版信息

Nat Immunol. 2024 Jan;25(1):117-128. doi: 10.1038/s41590-023-01685-w. Epub 2023 Nov 27.

Abstract

In cancer and infections, self-renewing stem-like CD8 T cells mediate the response of immunotherapies and replenish terminally exhausted T cells and effector-like T cells. However, the programs governing the lineage choice in chimeric antigen receptor (CAR) T cells are unclear. Here, by simultaneously profiling single-cell chromatin accessibility and transcriptome in the same CAR T cells, we identified heterogeneous chromatin states within CD8 T cell subsets that foreshadowed transcriptional changes and were primed for regulation by distinct transcription factors. Transcription factors that controlled each CD8 T cell subset were regulated by high numbers of enhancers and positioned as hubs of gene networks. FOXP1, a hub in the stem-like network, promoted expansion and stemness of CAR T cells and limited excessive effector differentiation. In the effector network, KLF2 enhanced effector CD8 T cell differentiation and prevented terminal exhaustion. Thus, we identified gene networks and hub transcription factors that controlled the differentiation of stem-like CD8 CAR T cells into effector or exhausted CD8 CAR T cells.

摘要

在癌症和感染中,自我更新的干细胞样 CD8 T 细胞介导免疫疗法的反应,并补充终末耗竭的 T 细胞和效应样 T 细胞。然而,嵌合抗原受体 (CAR) T 细胞中谱系选择的调控程序尚不清楚。在这里,我们通过同时对相同的 CAR T 细胞进行单细胞染色质可及性和转录组分析,鉴定了 CD8 T 细胞亚群内的异质性染色质状态,这些状态预示着转录变化,并为不同的转录因子的调控做好了准备。控制每个 CD8 T 细胞亚群的转录因子受大量增强子的调控,并作为基因网络的枢纽定位。FOXP1 是干细胞样网络的枢纽,促进了 CAR T 细胞的扩增和干细胞特性,并限制了过度的效应分化。在效应网络中,KLF2 增强了效应 CD8 T 细胞的分化,并防止了终末耗竭。因此,我们确定了控制干细胞样 CD8 CAR T 细胞向效应或耗竭的 CD8 CAR T 细胞分化的基因网络和枢纽转录因子。

相似文献

1
FOXP1 and KLF2 reciprocally regulate checkpoints of stem-like to effector transition in CAR T cells.
Nat Immunol. 2024 Jan;25(1):117-128. doi: 10.1038/s41590-023-01685-w. Epub 2023 Nov 27.
2
BLIMP1 and NR4A3 transcription factors reciprocally regulate antitumor CAR T cell stemness and exhaustion.
Sci Transl Med. 2022 Nov 9;14(670):eabn7336. doi: 10.1126/scitranslmed.abn7336.
3
BATF regulates progenitor to cytolytic effector CD8 T cell transition during chronic viral infection.
Nat Immunol. 2021 Aug;22(8):996-1007. doi: 10.1038/s41590-021-00965-7. Epub 2021 Jul 19.
4
NR4A transcription factors limit CAR T cell function in solid tumours.
Nature. 2019 Mar;567(7749):530-534. doi: 10.1038/s41586-019-0985-x. Epub 2019 Feb 27.
5
Gfi1 controls the formation of effector CD8 T cells during chronic infection and cancer.
bioRxiv. 2024 Apr 21:2024.04.18.579535. doi: 10.1101/2024.04.18.579535.
7
Epigenetic signature of PD-1+ TCF1+ CD8 T cells that act as resource cells during chronic viral infection and respond to PD-1 blockade.
Proc Natl Acad Sci U S A. 2019 Jul 9;116(28):14113-14118. doi: 10.1073/pnas.1903520116. Epub 2019 Jun 21.
8
BACH2 enforces the transcriptional and epigenetic programs of stem-like CD8 T cells.
Nat Immunol. 2021 Mar;22(3):370-380. doi: 10.1038/s41590-021-00868-7. Epub 2021 Feb 11.
9
Transcriptional regulatory network for the establishment of CD8 T cell exhaustion.
Exp Mol Med. 2021 Feb;53(2):202-209. doi: 10.1038/s12276-021-00568-0. Epub 2021 Feb 24.
10
Loss of PBAF promotes expansion and effector differentiation of CD8 T cells during chronic viral infection and cancer.
Cell Rep. 2023 Jun 27;42(6):112649. doi: 10.1016/j.celrep.2023.112649. Epub 2023 Jun 16.

引用本文的文献

1
Guardians of silence: transcriptional networks in T cell quiescence.
Exp Mol Med. 2025 Aug 4. doi: 10.1038/s12276-025-01516-y.
2
5
Hdac1 as an early determinant of intermediate-exhausted CD8 T cell fate in chronic viral infection.
Proc Natl Acad Sci U S A. 2025 May 13;122(19):e2502256122. doi: 10.1073/pnas.2502256122. Epub 2025 May 7.
6
BCOR and ZC3H12A suppress a core stemness program in exhausted CD8+ T cells.
J Exp Med. 2025 Aug 4;222(8). doi: 10.1084/jem.20241133. Epub 2025 May 6.
7
Enhanced interpretation of immune cell phenotype and function through a rhesus macaque single-cell atlas.
Cell Genom. 2025 May 14;5(5):100849. doi: 10.1016/j.xgen.2025.100849. Epub 2025 Apr 14.
8
Supercharging CAR-T cells through transcriptional and epigenetic armoring.
Theranostics. 2025 Feb 18;15(8):3345-3367. doi: 10.7150/thno.107908. eCollection 2025.
9
Cytotoxic KLRG1+ IL-7R- effector CD8+ T cells distinguish kidney transplant recipients controlling cytomegalovirus reactivation.
Front Immunol. 2025 Feb 14;16:1542531. doi: 10.3389/fimmu.2025.1542531. eCollection 2025.
10
KLF2 maintains lineage fidelity and suppresses CD8 T cell exhaustion during acute LCMV infection.
Science. 2025 Jan 2;387(6735):eadn2337. doi: 10.1126/science.adn2337. Epub 2025 Feb 14.

本文引用的文献

1
Integrated single-cell profiling dissects cell-state-specific enhancer landscapes of human tumor-infiltrating CD8 T cells.
Mol Cell. 2023 Feb 16;83(4):622-636.e10. doi: 10.1016/j.molcel.2022.12.029. Epub 2023 Jan 18.
2
Clonal lineage tracing reveals mechanisms skewing CD8+ T cell fate decisions in chronic infection.
J Exp Med. 2023 Jan 2;220(1). doi: 10.1084/jem.20220679. Epub 2022 Oct 31.
4
6
An NK-like CAR T cell transition in CAR T cell dysfunction.
Cell. 2021 Dec 9;184(25):6081-6100.e26. doi: 10.1016/j.cell.2021.11.016. Epub 2021 Dec 2.
7
A reservoir of stem-like CD8 T cells in the tumor-draining lymph node preserves the ongoing antitumor immune response.
Sci Immunol. 2021 Oct;6(64):eabg7836. doi: 10.1126/sciimmunol.abg7836. Epub 2021 Sep 2.
8
Antigen dominance hierarchies shape TCF1 progenitor CD8 T cell phenotypes in tumors.
Cell. 2021 Sep 16;184(19):4996-5014.e26. doi: 10.1016/j.cell.2021.08.020.
10
Functional HPV-specific PD-1 stem-like CD8 T cells in head and neck cancer.
Nature. 2021 Sep;597(7875):279-284. doi: 10.1038/s41586-021-03862-z. Epub 2021 Sep 1.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验